{"id":61671,"date":"2020-01-30T16:05:26","date_gmt":"2020-01-30T16:05:26","guid":{"rendered":"https:\/\/leitat.org\/blog\/developing-molecular-signatures-for-s100-proteins\/"},"modified":"2025-02-05T20:27:54","modified_gmt":"2025-02-05T20:27:54","slug":"developing-molecular-signatures-for-s100-proteins","status":"publish","type":"post","link":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/","title":{"rendered":"Developing molecular signatures for S100 proteins"},"content":{"rendered":"<p style=\"text-align: justify;\">The CDTI has granted two new loans to <a href=\"http:\/\/www.atryshealth.com\/\">Atrys<\/a> in the Cervera framework, in the field of liquid biopsy and AI applied to diagnostic imaging. The Cervera projects aim to help individual R&amp;D projects developed by companies that collaborate with state-level Technology Centers, such as Leitat, in priority technologies.<\/p>\n<p style=\"text-align: justify;\">The financing, which represents 85% of the total projects, will reinforce translational research, one of the company&#8217;s strategic lines. It will also allow the introduction of quantitative improvements in its competitiveness in two areas especially relevant to Atrys: telemedicine and oncological diagnosis.<\/p>\n<p style=\"text-align: justify;\">The ALARMINAS project, in which Leitat, the Puerta de Hierro Majadahonda University Hospital (HUPDHM), and the Ja\u00e9n Hospital Complex (CHJ) will participate, is the development of a molecular signature of alarmines (S100 proteins) from blood samples from breast cancer and lung cancer patients. Alarmines are molecules that are only released when there is cellular damage. Through the parameters obtained, it will be possible to establish a personalized prognosis of the patient that guides his future treatment.<\/p>\n<p style=\"text-align: justify;\">Liquid biopsy techniques seek to diagnose the patient in a simple and less invasive way (through blood samples), monitor the response to treatment, and establish personalized treatments. This type of methodology can also allow predicting the occurrence of relapses and generate meta-analyses that support medical decision-making.<\/p>\n<p style=\"text-align: justify;\">The financing granted to ALARMINAS, at 3 years and zero interest, amounts to \u20ac625,000, equivalent to 85% of the budget.<\/p>\n<p style=\"text-align: justify;\">More information <strong>here.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The CDTI has granted two new loans to Atrys in the Cervera framework, in the field of liquid biopsy and AI applied to diagnostic imaging. The Cervera projects aim to help individual R&amp;D projects developed by companies that collaborate with state-level Technology Centers, such as Leitat, in priority technologies. The financing, which represents 85% of [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":51747,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[146,142],"tags":[102],"class_list":["post-61671","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cdti-en","category-health-technologies-en","tag-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Developing molecular signatures for S100 proteins - Leitat Technological Center<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Developing molecular signatures for S100 proteins - Leitat Technological Center\" \/>\n<meta property=\"og:description\" content=\"The CDTI has granted two new loans to Atrys in the Cervera framework, in the field of liquid biopsy and AI applied to diagnostic imaging. The Cervera projects aim to help individual R&amp;D projects developed by companies that collaborate with state-level Technology Centers, such as Leitat, in priority technologies. The financing, which represents 85% of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/\" \/>\n<meta property=\"og:site_name\" content=\"Leitat Technological Center\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-30T16:05:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T20:27:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Comunicaci\u00f3n Leitat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunicaci\u00f3n Leitat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/\"},\"author\":{\"name\":\"Comunicaci\u00f3n Leitat\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131\"},\"headline\":\"Developing molecular signatures for S100 proteins\",\"datePublished\":\"2020-01-30T16:05:26+00:00\",\"dateModified\":\"2025-02-05T20:27:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/\"},\"wordCount\":242,\"publisher\":{\"@id\":\"https:\/\/leitat.org\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg\",\"keywords\":[\"News\"],\"articleSection\":[\"CDTI\",\"Health technologies\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/\",\"url\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/\",\"name\":\"Developing molecular signatures for S100 proteins - Leitat Technological Center\",\"isPartOf\":{\"@id\":\"https:\/\/leitat.org\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg\",\"datePublished\":\"2020-01-30T16:05:26+00:00\",\"dateModified\":\"2025-02-05T20:27:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#primaryimage\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg\",\"width\":1440,\"height\":960},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"HOME\",\"item\":\"https:\/\/leitat.org\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDTI\",\"item\":\"https:\/\/leitat.org\/en\/blog\/category\/cdti-en\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Developing molecular signatures for S100 proteins\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/leitat.org\/en\/#website\",\"url\":\"https:\/\/leitat.org\/en\/\",\"name\":\"Leitat Technological Center\",\"description\":\"Managing Technologies\",\"publisher\":{\"@id\":\"https:\/\/leitat.org\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/leitat.org\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/leitat.org\/en\/#organization\",\"name\":\"Leitat Technological Center\",\"url\":\"https:\/\/leitat.org\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"contentUrl\":\"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg\",\"width\":226,\"height\":78,\"caption\":\"Leitat Technological Center\"},\"image\":{\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131\",\"name\":\"Comunicaci\u00f3n Leitat\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g\",\"caption\":\"Comunicaci\u00f3n Leitat\"},\"sameAs\":[\"https:\/\/leitat.org\"],\"url\":\"https:\/\/leitat.org\/en\/blog\/author\/comunica-wp\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Developing molecular signatures for S100 proteins - Leitat Technological Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Developing molecular signatures for S100 proteins - Leitat Technological Center","og_description":"The CDTI has granted two new loans to Atrys in the Cervera framework, in the field of liquid biopsy and AI applied to diagnostic imaging. The Cervera projects aim to help individual R&amp;D projects developed by companies that collaborate with state-level Technology Centers, such as Leitat, in priority technologies. The financing, which represents 85% of [&hellip;]","og_url":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/","og_site_name":"Leitat Technological Center","article_published_time":"2020-01-30T16:05:26+00:00","article_modified_time":"2025-02-05T20:27:54+00:00","og_image":[{"width":1440,"height":960,"url":"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg","type":"image\/jpeg"}],"author":"Comunicaci\u00f3n Leitat","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Comunicaci\u00f3n Leitat","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#article","isPartOf":{"@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/"},"author":{"name":"Comunicaci\u00f3n Leitat","@id":"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131"},"headline":"Developing molecular signatures for S100 proteins","datePublished":"2020-01-30T16:05:26+00:00","dateModified":"2025-02-05T20:27:54+00:00","mainEntityOfPage":{"@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/"},"wordCount":242,"publisher":{"@id":"https:\/\/leitat.org\/en\/#organization"},"image":{"@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg","keywords":["News"],"articleSection":["CDTI","Health technologies"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/","url":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/","name":"Developing molecular signatures for S100 proteins - Leitat Technological Center","isPartOf":{"@id":"https:\/\/leitat.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#primaryimage"},"image":{"@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#primaryimage"},"thumbnailUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg","datePublished":"2020-01-30T16:05:26+00:00","dateModified":"2025-02-05T20:27:54+00:00","breadcrumb":{"@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#primaryimage","url":"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2020\/01\/LABORATORI-DE-CULTIU-CELULAR-031.jpg","width":1440,"height":960},{"@type":"BreadcrumbList","@id":"https:\/\/leitat.org\/en\/blog\/developing-molecular-signatures-for-s100-proteins\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"HOME","item":"https:\/\/leitat.org\/en\/home\/"},{"@type":"ListItem","position":2,"name":"CDTI","item":"https:\/\/leitat.org\/en\/blog\/category\/cdti-en\/"},{"@type":"ListItem","position":3,"name":"Developing molecular signatures for S100 proteins"}]},{"@type":"WebSite","@id":"https:\/\/leitat.org\/en\/#website","url":"https:\/\/leitat.org\/en\/","name":"Leitat Technological Center","description":"Managing Technologies","publisher":{"@id":"https:\/\/leitat.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leitat.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/leitat.org\/en\/#organization","name":"Leitat Technological Center","url":"https:\/\/leitat.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","contentUrl":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/10\/logo-leitat.svg","width":226,"height":78,"caption":"Leitat Technological Center"},"image":{"@id":"https:\/\/leitat.org\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/leitat.org\/en\/#\/schema\/person\/ca8dc97489cd821df9e0c42930e89131","name":"Comunicaci\u00f3n Leitat","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce5e10560c8753dc6a31f108c84f08103b3e4bb78f97dde95a1445d45abbb09a?s=96&d=mm&r=g","caption":"Comunicaci\u00f3n Leitat"},"sameAs":["https:\/\/leitat.org"],"url":"https:\/\/leitat.org\/en\/blog\/author\/comunica-wp\/"}]}},"_links":{"self":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/61671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/comments?post=61671"}],"version-history":[{"count":1,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/61671\/revisions"}],"predecessor-version":[{"id":61685,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/posts\/61671\/revisions\/61685"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/media\/51747"}],"wp:attachment":[{"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/media?parent=61671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/categories?post=61671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leitat.org\/en\/wp-json\/wp\/v2\/tags?post=61671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}